Pluri (PLUR) Net Equity Issued and Repurchased (2010 - 2025)
Pluri (PLUR) posted quarterly Net Equity Issued and Repurchased of -$388000.0 for Q2 2025, down 3780.0% quarter-over-quarter from -$10000.0 in Q2 2023.
Pluri (PLUR) Net Equity Issued and Repurchased (2010 - 2025) Analysis & Trends
Pluri (PLUR) has reported Net Equity Issued and Repurchased for 12 consecutive years, with -$388000.0 the latest figure, recorded in Q2 2025.
- In Q2 2025, Net Equity Issued and Repurchased changed N/A year-over-year to -$388000.0; the TTM figure through Jun 2025 stood at $1.9 million (changed N/A YoY), while the FY2025 annual figure was $9.6 million, up 10427.47% from the prior year.
- Net Equity Issued and Repurchased slipped to -$388000.0 in Q2 2025 per PLUR's latest filing, from -$10000.0 in the prior quarter.
- Across five years, Net Equity Issued and Repurchased topped out at $35.7 million in Q1 2021 and bottomed at -$388000.0 in Q2 2025.
- Historically, Net Equity Issued and Repurchased has averaged $7.5 million across 3 years, with a median of -$10000.0 in 2023.
- On a YoY basis, Net Equity Issued and Repurchased climbed as much as 561.87% in 2021 and fell as far as 100.08% in 2021.
- Pluri's Net Equity Issued and Repurchased stood at -$39000.0 in 2021, then soared by 74.36% to -$10000.0 in 2023, then sank by 3780.0% to -$388000.0 in 2025.
- Business Quant data shows PLUR's Net Equity Issued and Repurchased at -$388000.0 in Q2 2025, -$10000.0 in Q2 2023, and $2.3 million in Q1 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 49.20 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Pluri | 16.21 Mn | 3.72 Mn | 86,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -388,000.00 |
| Jun 30, 2025 | -388,000.00 |
| Jun 30, 2023 | -10,000.00 |
| Jun 30, 2023 | -10,000.00 |
| Mar 31, 2023 | 2.34 Mn |
| Mar 31, 2023 | 2.34 Mn |
| Jun 30, 2021 | -39,000.00 |
| Jun 30, 2021 | -39,000.00 |
| Mar 31, 2021 | 35.71 Mn |
| Mar 31, 2021 | 35.71 Mn |
| Jun 30, 2020 | 46.80 Mn |
| Jun 30, 2020 | 46.80 Mn |
| Mar 31, 2020 | 5.40 Mn |
| Mar 31, 2020 | 5.40 Mn |
| Dec 31, 2019 | 3.99 Mn |
| Dec 31, 2019 | 3.99 Mn |
| Sep 30, 2019 | 1.98 Mn |
| Sep 30, 2019 | 1.98 Mn |
| Jun 30, 2019 | 19.76 Mn |
| Jun 30, 2019 | 19.76 Mn |